Coronavirus (COVID-19) Vaccines
UNC Health is following the COVID-19 vaccine distribution guidance released by the Centers for Disease Control and Prevention (CDC) and North Carolina Department of Health and Human Services (NCDHHS) and is committed to sharing the latest facts about the vaccines with you. We are now offering vaccinations according to the phased eligibility recommendations. It is important to read all of the available information about the COVID-19 vaccines so you can make the best decision for yourself and your loved ones. Here's what you need to know:
Walk-ins Now Available
UNC Health’s vaccination clinics have started accepting walk-in appointments for anyone age 18 and older, as we encourage more North Carolinians to get their shot. That includes our largest vaccine clinic at the Friday Center in Chapel Hill, which will accept walk-ins Monday- Friday from 8:30 a.m. to 4:00 p.m.
As part of our mission to improve the health and well-being of North Carolinians, we are committed to health equity and enabling everyone to receive the vaccine. This includes both our coworkers and the communities we serve. Healthcare personnel in Phase 1A are still eligible to receive a vaccination even after beginning distribution to Phase 1B and beyond. Vaccines are one important tool to help us fight COVID-19, but we still need to use all of our tools if we hope to end this pandemic. This means you still need to practice physical distancing, wear a mask, frequently wash your hands and stay home when you're sick.
What Cancer Patients at UNC Health Need to Know
We believe the COVID-19 vaccine is safe and could offer important protection for people with cancer, who may be at higher risk for complications from the virus. We will recommend that most people with cancer get the vaccine—regardless of the type of treatment they are receiving.
For now, the only groups of cancer patients for which we are not currently recommending the vaccine are patients who received a bone marrow transplant or cellular therapy (CAR-T) less than three months ago. Further, we recommend that patients with cancer who are on a clinical trial or have platelets that are less than 30,000 should talk with their oncology provider before receiving the vaccine.
Now that the vaccine is available to the public, we are following CDC and NCDHHS guidance for vaccinating those most at risk first, including those with high-risk medical conditions, such as cancer.
Please do not contact your provider about scheduling a vaccine appointment at this time. We appreciate your patience and understanding.